Rubric Capital Management LP 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI | Rubric Capital Management LP | 5,026,931 6.920% | -657,489 (-11.57%) | Filing |
| 2024-02-12 06:06 am Unchanged | 2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Rubric Capital Management LP | 5,684,420 8.900% | 0 (Unchanged) | Filing |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Rubric Capital Management LP | 5,684,420 9.490% | 5,684,420 (New Position) | Filing |